Bank of New York Mellon »

Mersana Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 379k 4.48
2023-12-31 $897k 387k 2.32
2023-09-30 $477k 376k 1.27
2023-06-30 $1.2M 377k 3.29
2023-03-31 $1.5M 370k 4.11
2022-12-31 $2.2M 368k 5.86
2022-09-30 $0 361k 0.00
2022-06-30 $1.6M 344k 4.62
2022-03-31 $1.1M 283k 3.99
2021-12-31 $1.8M 280k 6.59
2021-09-30 $2.6M 271k 9.42
2021-06-30 $3.4M 249k 13.58
2021-03-31 $4.2M 262k 16.18
2020-12-31 $7.4M 277k 26.61
2020-09-30 $5.2M 278k 18.62
2020-06-30 $8.2M 271k 30.30
2020-03-31 $1.1M 195k 5.84
2019-12-31 $1.1M 194k 5.73
2019-09-30 $161k 101k 1.59
2019-06-30 $434k 107k 4.05
2019-03-31 $208k 39k 5.36
2018-12-31 $160k 39k 4.09
2018-09-30 $328k 33k 9.96
2018-06-30 $565k 32k 17.88
2018-03-31 $394k 25k 15.88
2017-12-31 $256k 15k 16.59